BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Bone cancer

1. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. AXIN1
    [Clinical Outcome] [